1.
AGA Clinical Practice Update on Colorectal and Pancreatic Cancer Risk and Screening in BRCA1 and BRCA2 Carriers: Commentary.
Kupfer, SS, Gupta, S, Weitzel, JN, Samadder, J
Gastroenterology. 2020;(2):760-764
2.
MicroRNAs in prostate cancer: Functional role as biomarkers.
Kanwal, R, Plaga, AR, Liu, X, Shukla, GC, Gupta, S
Cancer letters. 2017;:9-20
Abstract
MicroRNAs (miRNAs) are small endogenous non-coding molecules that alters gene expression through post-transcriptional regulation of messenger RNA. Compelling evidence suggest the role of miRNA in cancer biology having potential as diagnostic, prognostic and predictive biomarkers. This review summarizes the current knowledge on miRNA deregulated in prostate cancer and their role as oncogene, tumor suppressor and metastasis regulators. The emerging information elucidating the biological function of miRNA is promising and may lead to their potential usefulness as diagnostic/prognostic markers and development as effective therapeutic tools for management of prostate cancer.
3.
Selenium as marker for cancer risk and prevention.
Lener, M, Jaworska, K, Muszyńska, M, Sukiennicki, G, Durda, K, Gupta, S, Złowocka-Perłowska, E, Kładny, J, Wiechowska-Kozłowska, A, Grodzki, T, et al
Polski przeglad chirurgiczny. 2012;(9):470-5